Envoyer à un ami
RSS
google +
Version imprimable

Actualité (Vieillissement)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

White Book on Parkinson's disease    epda.eu.com

At the 2nd National Meeting of Parkinson's Italia, people with Parkinson's from all over Italy met up in Vasto, Abruzzo, the national group together with the local associations have instigated a new [...]

Dopamine receptor mapping with PET imaging in Parkinson's disease    epda.eu.com

In this article authors aim to review the role of PET imaging in understanding the postsynaptic dopaminergic mechanisms in PD. PET studies have allowed us to gain important insights into the function[...]

Biotie announces start of tozadenant Phase 3 Study in Parkinson's disease    epda.eu.com

Biotie announces the start of the Phase 3 clinical study of tozadenant, an investigational adenosine A2a receptor antagonist, in patients with Parkinson's disease (PD) experiencing levodopa related e[...]

Parkinson Bizkaia Association (ASPARBI) Campaign - 'I join the movement against Parkinson'    epda.eu.com

Parkinson Bizkaia Association (ASPARBI) recently launched the campaign 'I join the movement against Parkinson' with the aim of promoting an easily recognisable gesture which identifies Parkinson's di[...]

EEPO Review on Upskilling Unemployed Adults: The Organisation, Profiling and Targeting of Training Provision    europa.eu

EEPO's Review on Upskilling Unemployed Adults: The Organisation, Profiling and Targeting of Training Provision was published in June 2015.[...]

Reform of military pensions in Romania and other social developments in Cyprus and Hungary    europa.eu

Three new Flash Reports produced by the European Social Policy Network (ESPN) are now available and provide information on recent developments in social protection in Cyprus, Romania and Hungary.[...]

NHS England approves routine commissioning for Parkinson's treatment Duodopa    epda.eu.com

AbbVie welcomes the decision by NHS England to routinely commission Duodopa (Levodopa-carbidopa intestinal gel - LCIG) for the first time.[...]

UNC team uses cellular bubbles to deliver Parkinson's meds directly to brain    epda.eu.com

Researchers at the University of North Carolina at Chapel Hill have used exosomes tiny bubbles of protein and fat produced naturally by cells to bypass the body's defences and deliver a potent biopha[...]

Campaign success: NHS England to fund Duodopa    epda.eu.com

The NHS in England has announced they will fund Duodopa, a life-changing drug for people with advanced Parkinson's. This means that should a specialist Parkinson's clinician prescribe Duodopa, a pers[...]

Herantis Pharma granted almost 3 million Euro government loan for Parkinson study    epda.eu.com

Tekes, the Finnish Funding Agency for Innovation, has granted a 2,903,000 EUR R&D loan to Herantis Pharma Plc to support its clinical study of CDNF for the treatment of Parkinson's disease. The l[...]

Parkinson's disease with and without preceding essential tremor-similar phenotypes: a pilot study    epda.eu.com

The fact that non-motor symptoms were similar in ET-PD gives rise to the hypothesis that also the prodromal phase of PD is similar in ET patients later developing classical PD compared to individuals[...]

Diabetes drug found useless for Parkinson's    epda.eu.com

The diabetes drug pioglitazone (Actos) isn't likely to slow the progression of early Parkinson's disease, researchers reported.[...]

New study calls for partnering of Parkinson's research community with patient groups to improve effectiveness of clinical trials    epda.eu.com

Despite an urgent need for new medications, clinical trials in Parkinson's disease (PD) have a relatively low rate of success. The reasons for this are complex, prompting a group of investigators fro[...]

Adherence to medical plans for older people - Just Published - EU Bookshop    europa.eu

A European Innovation Partnership on Active and Healthy Ageing priority[...]

Impact of earlier use of NEUPRO (rotigotine transdermal patch) in Parkinson's disease patients discussed at first EAN congress    epda.eu.com

Results of the post-hoc analysis investigating the impact of 6-month earlier versus postponed initiation of NEUPRO (rotigotine transdermal patch) in patients with early-stage Parkinson's disease (PD)[...]

Parkinson disease appears associated with many cancers in Taiwan    epda.eu.com

Parkinson disease (PD) appeared associated with 16 types of cancer in a study in Taiwan, an effort to explain the association in an East Asian population because most prior research has been conducte[...]

NeuroDerm poster selected for blue ribbon highlights session during International Congress of Parkinson's & Movement disorders    epda.eu.com

NeuroDerm Ltd., a clinical-stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, announced that its poster presentation, [...]

Parkinson disease appears associated with many cancers in Taiwan    epda.eu.com

Parkinson disease (PD) appeared associated with 16 types of cancer in a study in Taiwan, an effort to explain the association in an East Asian population because most prior research has been conducte[...]

1 Hour More: A storytelling project to improve Parkinson's disease patients' quality of life    epda.eu.com

With the aim of raising public attention about Parkinson's disease (PD) at an international level, providing people with PD emotional and practical support, the European Parkinson's Disease Associati[...]

Rudeness and hostility blight lives of 69,000 with Parkinson's    epda.eu.com

An estimated 69,000 people in the UK with Parkinson's have experienced hostility and rudeness from members of the public according to data released today by Parkinson's UK on the launch of Parkinson'[...]

Acorda presents data on inhaled levodopa therapy CVT-301 at International Congress of Parkinson's Disease and Movement Disorders    epda.eu.com

Acorda Therapeutics, Inc. today presented data from a Phase 2b clinical trial of CVT-301, an inhaled levodopa (L-dopa) under development for the episodic treatment of OFF episodes associated with Par[...]

Gene therapy prevents Parkinson's disease in animal model, says Pitt study    epda.eu.com

Gene therapy to reduce production of a brain protein successfully prevented development of Parkinson's disease in an animal study, according to researchers at the University of Pittsburgh School of M[...]

Acadia Pharmaceuticals presents integrated data from phase III program with Nuplazid™ (pimavanserin) for Parkinson's psychosis    epda.eu.com

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announce[...]

FDA approves brain implant to help reduce Parkinson's disease and essential tremor symptoms    epda.eu.com

The U.S. Food and Drug Administration today approved the Brio Neurostimulation System, an implantable deep brain stimulation device to help reduce the symptoms of Parkinson's disease and essential tr[...]

NTCELL clinical study in Parkinson's meets endpoints    epda.eu.com

Living Cell Technologies Limited (LCT) today announced results from a Phase I/IIa clinical study of NTCELL, an experimental regenerative cell therapy being studied as a disease-modifying agent in Par[...]

Melior Discovery receives patent approval from U.S. Patent and Trademark Office for new Parkinson's disease drug candidate    epda.eu.com

Melior Discovery, Inc. announced today that the United States Patent and Trademark Office (USTPO) has awarded a patent to the company for its Parkinson's disease candidate, MLR-1019. The patent cover[...]

Adamas receives Orphan drug designation for ADS-5102 for treatment of levodopa-induced dyskinesia associated with Parkinson's    epda.eu.com

Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia associated with Pa[...]

Trust your gut: E. coli may hold one of the keys to treating Parkinson's    epda.eu.com

E. coli usually brings to mind food poisoning and beach closures, but researchers recently discovered a protein in E. coli that inhibits the accumulation of potentially toxic amyloids - a hallmark of[...]

Congratulations to those who inspire others.Parkinson's Award Recipients    epda.eu.com

Join World Parkinson's Program in congratulating the recipients of the Dr.Rana International Parkinson's Community Service Award for 2014[...]

International Stem Cell Corporation presents data from Parkinson's disease program at AAN Annual Meeting    epda.eu.com

International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the company has be[...]

The Parkinson Alliance Reports Findings Pertaining to Exercise in Parkinson's Disease    epda.eu.com

The Parkinson Alliance (PA) completed their 18th survey based research, entitled Exercise in Parkinson's Disease With and Without DBS: A Closer Look from the Patient's Perspective, to investigate the[...]

My PD Journey: Urgent action needed to address challenges of Parkinson's disease in Europe with numbers set to double by 2030    epda.eu.com

My PD Journey, an unprecedented multi-stakeholder initiative led by the European Parkinson's Disease Association (EPDA), gathered last week with high-level EU officials and stakeholders from across E[...]

The 4th Copenhagen Parkinson Unity Walk    epda.eu.com

The 4th Copenhagen Parkinson Unity Walk on Saturday 30th May 2015, aims to increase public awareness of the illness as well as emphasising the importance of exercise for the wellbeing of people diagn[...]

Rudeness and hostility blight lives of 69,000 with Parkinson's    epda.eu.com

An estimated 69,000 people in the UK with Parkinson's have experienced hostility and rudeness from members of the public according to data released today by Parkinson's UK on the launch of Parkinson'[...]

Diary app helps track disease progress in Parkinson's patients    epda.eu.com

An iPad app diary may help track Parkinson's disease symptoms and have implications for clinical care, an ongoing study indicates.[...]

Boston Scientific announces strategic collaboration with Brainlab AG    epda.eu.com

Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical n[...]

Critical Path Institute secures regulatory support for Parkinson's and Alzheimer's disease biomarkers    epda.eu.com

Critical Path Institute (C-Path) announced that the U.S. Food and Drug Administration (FDA) has issued three Letters of Support to C-Path's Coalition Against Major Diseases (CAMD) consortium for the [...]

Parkinson's Life a new 'webzine' for the international Parkinson's community now live!    epda.eu.com

A new and innovative magazine-style website has been launched to inspire and inform the international Parkinson's community.[...]

The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson's disease    epda.eu.com

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialisation of [...]

Amarantus receives notice of allowance for U.S. patent application for treatment of Parkinson's    epda.eu.com

Patent issuance will provide IP protection for lead product candidate eltoprazine for treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID)[...]

UNC team uses cellular bubbles to deliver Parkinson's meds directly to brain    epda.eu.com

Researchers at the University of North Carolina at Chapel Hill have used exosomes tiny bubbles of protein and fat produced naturally by cells to bypass the body's defences and deliver a potent biopha[...]

Zambon launches Xadago (safinamide) for patients with mid- to late-stage Parkinson's disease in Germany    epda.eu.com

Germany is the first country in which Xadago is available as an add-on to levodopa alone and in combination with other PD medications.[...]

Dutch king & queen visit children in hospital and learn about Parkinson's research    epda.eu.com

Dutch King Willem-Alexander and Queen Maxima visited children at Helen DeVos Children's Hospital and toured research labs at Van Andel Institute on Tuesday, June 2.[...]

The National Parkinson Foundation removes barriers to expert Parkinson's care through telemedicine    epda.eu.com

The National Parkinson Foundation (NPF) announced today that the Connect.Parkinson national research study, comparing telemedicine care delivered to remote patients from a Parkinson's disease centre [...]

Global Kinetics raises $14.8m to take its Parkinson's tech to the US    epda.eu.com

Australian health technology company Global Kinetics Corporation (GKC) has raised $14.8 million to expand its Parkinson's disease treatment technology to the United States.[...]

Amarantus opens clinical trial site & patient enrolment for eltoprazine phase 2b study in Parkinsons levodopa-induced dyskinesia    epda.eu.com

Amarantus BioScience Holdings, Inc., a biotechnology company announced that the first clinical trial site is now open for enrolment for the Phase 2b study of its lead product candidate eltoprazine fo[...]

Remarks by Vice-President Valdis Dombrovskis at the press conference on the social policy orientation debate    europa.eu

European Commission - Statement Strasbourg, 09 June 2015 Today, the Commission held an orientation debate on EU social policy and the main priorities of social policy for this mandate of the Commissi[...]

Research Headlines - Mapping cells for better Parkinson's research    europa.eu

Parkinson's disease is a common disorder with no cure available yet. An EU-funded project has produced a genetic and chemical map of the neurons affected by the disease, to support new research into [...]

Amarantus opens clinical trial site & patient enrolment for eltoprazine phase 2b study in Parkinsons levodopa-induced dyskinesia    epda.eu.com

Amarantus BioScience Holdings, Inc., a biotechnology company announced that the first clinical trial site is now open for enrolment for the Phase 2b study of its lead product candidate eltoprazine fo[...]

Dutch king & queen visit children in hospital and learn about Parkinson's research    epda.eu.com

Dutch King Willem-Alexander and Queen Maxima visited children at Helen DeVos Children's Hospital and toured research labs at Van Andel Institute on Tuesday, June 2.[...]

Global Kinetics raises $14.8m to take its Parkinson's tech to the US    epda.eu.com

Australian health technology company Global Kinetics Corporation (GKC) has raised $14.8 million to expand its Parkinson's disease treatment technology to the United States.[...]

The National Parkinson Foundation removes barriers to expert Parkinson's care through telemedicine    epda.eu.com

The National Parkinson Foundation (NPF) announced today that the Connect.Parkinson national research study, comparing telemedicine care delivered to remote patients from a Parkinson's disease centre [...]

Research seminar on self-employment    europa.eu

Supporting entrepreneurship and self-employment is an important part of the Europe 2020 Strategy for smart, sustainable and inclusive growth.[...]

Events - Rheumatology & Aging Conference 2015 - 8-11 September 2015, Cambridge, UK    europa.eu

This conference will focus on the cells that control the immune system, their function in health, disease and aging, and the role of inflammation on musculoskeletal diseases of aging. At the end of t[...]

The 4th Copenhagen Parkinson Unity Walk    epda.eu.com

The 4th Copenhagen Parkinson Unity Walk on Saturday 30th May 2015, aims to increase public awareness of the illness as well as emphasising the importance of exercise for the wellbeing of people diagn[...]

Gender gap in pensions in the EU - Just Published - EU Bookshop    europa.eu

Research note to the Latvian Presidency[...]

Innovative Financing: Opportunities for Active & Healthy Ageing (Brussels, 3 June 2015)    europa.eu

Innovative Financing: Opportunities for Active & Healthy Ageing (Brussels, 3 June 2015) - Directorate General for Health and Food Safety[...]

Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease    epda.eu.com

Study data confirm that LCIG is beneficial in the long-term treatment of advanced PD patients despite a decline in cognitive functions in a subgroup of patients, probably due to disease progression. [...]

Deep brain stimulation in Parkinson's disease: meta-analysis of randomized controlled trials    epda.eu.com

Although the number of RCTs obtained is small, the total sample size is relatively large, confirming the efficacy of DBS in the control of motor signs and improvement of patients' functionality and q[...]

Wearables & apps for Parkinson's disease: why big data & big names may not be small enough    epda.eu.com

While headlines recently surged over big organisations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson[...]

Zambon launches Xadago (safinamide) for patients with mid- to late-stage Parkinson's disease in Germany    epda.eu.com

Germany is the first country in which Xadago is available as an add-on to levodopa alone and in combination with other PD medications.[...]

Amarantus receives notice of allowance for U.S. patent application for treatment of Parkinson's    epda.eu.com

Patent issuance will provide IP protection for lead product candidate eltoprazine for treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID)[...]

2015 Ageing Report warns of growing cost of ageing population    epha.org

On 12 May the European Commission published The 2015 Ageing Report, which presents economic and budgetary projections for the 28 EU member states for the period 2013-2060. Though the total population[...]

Success Stories - Movement sensor device improves life quality for Parkinson's patients    europa.eu

A small sensor, headphones and a mobile phone - the elements of a prototype kit that is giving hope of relief for sufferers of Parkinson's disease. The European-backed research project being spearhea[...]

Vitamin D from different sources is inversely associated with Parkinson disease    epda.eu.com

Study data confirm the association between vitamin D deficiency and PD, and for the first time demonstrate an inverse association of 25(OH)D2 with PD. Given that 25(OH)D2 concentration is independent[...]

The Michael J. Fox Foundation and Prothena partner to accelerate discovery of novel biomarkers for Parkinson's disease    epda.eu.com

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development and commercialisation of [...]

Trust your gut: E. coli may hold one of the keys to treating Parkinson's    epda.eu.com

E. coli usually brings to mind food poisoning and beach closures, but researchers recently discovered a protein in E. coli that inhibits the accumulation of potentially toxic amyloids - a hallmark of[...]

UNC team uses cellular bubbles to deliver Parkinson's meds directly to brain    epda.eu.com

Researchers at the University of North Carolina at Chapel Hill have used exosomes tiny bubbles of protein and fat produced naturally by cells to bypass the body's defences and deliver a potent biopha[...]

Programme - Conference 'Innovative Financing Opportunities for Active & Healthy Ageing' (3 June 2015)    europa.eu

European Commission - Brussels, 3 June 2015   About the Conference [...]

Parkinson's Life a new 'webzine' for the international Parkinson's community now live!    epda.eu.com

A new and innovative magazine-style website has been launched to inspire and inform the international Parkinson's community.[...]

Boston Scientific announces strategic collaboration with Brainlab AG    epda.eu.com

Boston Scientific Corporation (NYSE: BSX) announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical n[...]

Diary app helps track disease progress in Parkinson's patients    epda.eu.com

An iPad app diary may help track Parkinson's disease symptoms and have implications for clinical care, an ongoing study indicates.[...]

Critical Path Institute secures regulatory support for Parkinson's and Alzheimer's disease biomarkers    epda.eu.com

Critical Path Institute (C-Path) announced that the U.S. Food and Drug Administration (FDA) has issued three Letters of Support to C-Path's Coalition Against Major Diseases (CAMD) consortium for the [...]

Gait and upper limb variability in Parkinson's disease patients with and without freezing of gait    epda.eu.com

Findings demonstrate that: (1) freezers have a higher spatial gait variability between freezing episodes; (2) freezing-like episodes of the upper limb occur in PD patients, and tend to be more pronou[...]

Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease    epda.eu.com

Oral administration of this extract significantly reduced dopaminergic cell loss, microgliosis, and accumulation of α-synuclein aggregates. Further, G115 administration fully prevented the developmen[...]

Testing the first portable system for monitoring patients with Parkinson's disease    epda.eu.com

The Technical Research Centre for Dependency Care and Autonomous Living (CETpD) of the Universitat Politècnica de Catalunya has developed a pioneering portable system for monitoring the motor status [...]

Skin may help spot Alzheimer's and Parkinson's disease    epda.eu.com

Scientists have proposed a new idea for detecting brain conditions including Alzheimer's - a skin test. Their work, which is at an early stage, found the same abnormal proteins that accumulate in the[...]

New Parkinson's campaign - Parkure - sets crowdfunding precedent    epda.eu.com

A team of experienced researchers, academics and biotechnologists joined forces under the new University of Edinburgh spin-out Parkure (http://parkure.co.uk) in order to fast-track academic research [...]

UK scientists find new approach to treat Parkinson's disease    epda.eu.com

UK scientists have developed a peptide that sticks to the protein that causes Parkinson's disease, stopping it from killing brain cells. The research highlights a potential new route for slowing the [...]

Michael J. Fox Foundation Analysis Reveals Gaps between Research Volunteers & Parkinson's Clinical Studies    epda.eu.com

A paper authored by The Michael J. Fox Foundation for Parkinson's Research (MJFF) published in the Journal of Parkinson's Disease highlights baseline findings from the first three years of operating [...]

First novel discovery of a physical predictor of freezing in Parkinson's disease    epda.eu.com

MediGait reports a study finding a simple test predicting development of freezing within two years for people with Parkinson's disease.[...]

The Parkinson Alliance Reports Findings Pertaining to Exercise in Parkinson's Disease    epda.eu.com

The Parkinson Alliance (PA) completed their 18th survey based research, entitled Exercise in Parkinson's Disease With and Without DBS: A Closer Look from the Patient's Perspective, to investigate the[...]

Statins may not lower Parkinson's risk    epda.eu.com

The use of statins may not be associated with lowering risk for Parkinson's disease, according to a new study led by researchers at Penn State College of Medicine and National Institute of Environmen[...]

My PD Journey: Urgent action needed to address challenges of Parkinson's disease in Europe with numbers set to double by 2030    epda.eu.com

My PD Journey, an unprecedented multi-stakeholder initiative led by the European Parkinson's Disease Association (EPDA), gathered last week with high-level EU officials and stakeholders from across E[...]

EDF & AGE PLATFORM CALL THE EUROPEAN COMMISSION FOR AN INCLUSIVE DIGITAL SINGLE MARKET STRATEGY    edf-feph.org

This website is supported by the European Union Programme for Employment and Social Solidarity – PROGRESS (2007-2013) One of the highest priorities of the current European Commission is to boost the[...]

Events - Dietary strategies for a healthy ageing - 18 May 2015, Milan, Italy    europa.eu

The proportion of people aged over 65 in Europe is predicted to increase from 25% to 40% by 2030, which is likely to create huge challenges. Research into the types of problem likely to lie ahead inc[...]

The 4th Copenhagen Parkinson Unity Walk    epda.eu.com

The 4th Copenhagen Parkinson Unity Walk on Saturday 30th May 2015, aims to increase public awareness of the illness as well as emphasising the importance of exercise for the wellbeing of people diagn[...]

Rudeness and hostility blight lives of 69,000 with Parkinson's    epda.eu.com

An estimated 69,000 people in the UK with Parkinson's have experienced hostility and rudeness from members of the public according to data released today by Parkinson's UK on the launch of Parkinson'[...]

New growth factor indicates possible regenerative effects in Parkinson's disease    epda.eu.com

Researchers have long sought treatments that can slow the progression of Parkinson's disease. Current treatments have for decades been only symptomatic in nature, supplying the neurotransmitter dopam[...]

New mhealth platform for Parkinson's disease management    epda.eu.com

Funded with 4.4 million Euros by the European Commission the project mHealth platform for Parkinson's Disease management (PD_Manager project), which will allow people with Parkinson to be followed by[...]

Success Stories - Vision of the future: new adaptable lens to prolong sight of aging eyes    europa.eu

As we age our eyes lose their ability to focus quickly on near and far objects. Presbyopia is a common problem that comes with aging, but its causes are not yet fully understood. There is evidence th[...]

Adamas receives Orphan drug designation for ADS-5102 for treatment of levodopa-induced dyskinesia associated with Parkinson's    epda.eu.com

Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia associated with Pa[...]

International Stem Cell Corporation presents data from Parkinson's disease program at AAN Annual Meeting    epda.eu.com

International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the company has be[...]

New research reveals how European Governments need to address health information gap to support healthy ageing    epda.eu.com

A new report, published today, by the International Longevity Centre UK (ILC-UK) and supported by an unrestricted grant from Pfizer, explores where consumers go to seek out health information and who[...]

Creatine Doesn't Slow Parkinson's Progression    epda.eu.com

Despite early promise and a great deal of interest in creatine monohydrate as a possible treatment for Parkinson's disease (PD), a large new double-blind, placebo-controlled trial found that this tre[...]

Breath test for Parkinson's disease    epda.eu.com

Experts believe that a simple breath test could help doctors detect and diagnose Parkinson's disease. The test looks for a unique signature of chemicals in exhaled breath.[...]

REMPARK Real-Time Parkinson's Monitoring System    epda.eu.com

Researchers at Polytechnic University of Catalonia, aka BarcelonaTECH, have developed and are testing the new REMPARK (Personal Health Device for the Remote and Autonomous Management of Parkinson's D[...]

Parkinson's disease: Stepping forth into exercise, stepping back into the world    epda.eu.com

From set-dancing to choir sessions, Mags Mullarney's social enterprise Move4Parkinson's is helping people with the degenerative condition to take control of their symptoms.[...]

Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms For Programming Deep Brain Stimulation In Parkinson's    epda.eu.com

Great Lakes NeuroTechnologies announced today they have completed two pilot studies demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson's disease.[...]

Amarantus Announces Publication of Eltoprazine Phase 2a Study for Treating Parkinson's Levodopa-Induced Dyskinesia    epda.eu.com

Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing diagnostics in neurology, and therapeutic products with the potential for orphan drug designation in the areas of n[...]

Parkinson's Study Dims Ambitions for Gene Flaw Carried by Brin    epda.eu.com

Two of Roche Holding AG's experimental drugs for Parkinson's disease caused lung toxicity in monkeys, researchers said, delivering a setback to one of the most promising pathways to a new type of tre[...]

A new tool for understanding Parkinson's disease    epda.eu.com

École Polytechnique Fédérale de Lausanne (EPFL) scientists have developed a new method that can accurately simulate the chemical modification of the protein behind Parkinson's disease. The techniqu[...]

Diagnosis by keyboard: By revealing loss of motor skills, typing patterns may help to identify early onset of Parkinson's    epda.eu.com

Analysing people's keystrokes as they type on a computer keyboard can reveal a great deal of information about the state of their motor function, according to a new study from Massachusetts Institute[...]

New blood signature analysis may help diagnose Parkinson's disease earlier    epda.eu.com

A new blood test may more accurately identify blood signatures, or biomarkers, for Parkinson's disease (PD), according to a new study published in the journal Movement Disorders.[...]

Neurologists find movement tracking device helps assess severity of Parkinson's disease    epda.eu.com

A device that measures movement and balance can effectively help assess and track the progression of Parkinson's disease, even when medications are used to reduce Parkinson's symptoms, UT Southwester[...]

Blood test aims to detect Parkinson's in early stages    epda.eu.com

Researchers have developed a blood test that they say could help neurologists detect Parkinson's disease and track the illness as it progresses.[...]

Tipping point of Parkinson's Disease, discovered by Cambridge University    epda.eu.com

Scientists believe they have found the tipping point in the brain which triggers Parkinson's Disease in a breakthrough which brings hope of future therapies.[...]

Neutron beams reveal how two potential pieces of Parkinson's puzzle fit    epda.eu.com

To understand diseases like Parkinson's, the tiniest of puzzles may hold big answers. That's why a team including scientists from the National Institute of Standards and Technology (NIST) have determ[...]

New technologies to help patients with Parkinson's disease    epda.eu.com

The research group of Life Supporting Technologies from Universidad Politécnica de Madrid (UPM) has developed a decision support system for healthcare experts that helps them to manage the informatio[...]

Conference 'Innovative Financing Opportunities for Active & Healthy Ageing' (3 June 2015)    europa.eu

European Commission - Brussels, 3 June 2015   About the Conference [...]

Parkinson's Disease Severity and Use of Dopaminergic Medications    epda.eu.com

The outcomes measured at the beginning of the study showed lower disease burden for participants on initial DA monotherapy compared to those taking combined LD and DA therapy after controlling for ag[...]

A pen for people with Parkinson's    epda.eu.com

A brain tumor convinced Lucy Jung to design for those in need. Her arc pen can help patients with Parkinson's disease write legibly.[...]

Low-frequency deep brain stimulation improves difficult-to-treat Parkinson's symptoms    epda.eu.com

Parkinson's disease patients treated with low-frequency deep brain stimulation show significant improvements in swallowing dysfunction and freezing of gait over typical high-frequency treatment.[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.